Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.
about
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidateTime-lapse imaging of red blood cell invasion by the rodent malaria parasite Plasmodium yoeliiStructural Characterization of Apical Membrane Antigen 1 (AMA1) from Toxoplasma gondiiIdentification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1)Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaquesPhage-displayed peptides bind to the malarial protein apical membrane antigen-1 and inhibit the merozoite invasion of host erythrocytes.Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1Analysis of the Plasmodium and Anopheles transcriptomes during oocyst differentiationBinding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1Mimotopes of apical membrane antigen 1: Structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogueImpact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult MaliansPhase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children.Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaIdentification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infectionConstruction of transgenic Plasmodium berghei as a model for evaluation of blood-stage vaccine candidate of Plasmodium falciparum chimeric protein 2.9.Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults.Host-Parasite Interactions in Human Malaria: Clinical Implications of Basic ResearchPlasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malariaImmunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRon2 Does Not Improve the In Vitro Efficacy.Targeted disruption of py235ebp-1: invasion of erythrocytes by Plasmodium yoelii using an alternative Py235 erythrocyte binding protein.posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket.Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coliHigh-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic responseVaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malariaImmunity to asexual blood stage malaria and vaccine approaches.Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.Crystal structure of Plasmodium knowlesi apical membrane antigen 1 and its complex with an invasion-inhibitory monoclonal antibody.High-Level Expression, Purification and Characterization of A Recombinant Plasmodium vivax Apical Membrane Antigen 1: Implication for vivax Malaria Vaccine DevelopmentComparative Antibody Responses Against three Antimalarial Vaccine Candidate Antigens from Urban and Rural Exposed Individuals in Gabon.In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune responseA diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits.The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.
P2860
Q24648408-712ACB0B-A9C5-42C9-B728-0E205EE09767Q27333248-FFB939D7-4408-42B3-86AB-88F3990FD171Q27660294-09041463-31EF-41A4-B800-058B0554D134Q28478668-D6CD44FB-029B-4BBD-B7E7-92B63286B6CFQ28742239-F1BDD3EB-3027-4344-99C6-0E9A7559C39BQ30863749-2D5E893A-9E67-4134-BE6C-D34E91920FF8Q30942598-EDEB32B2-ABF0-4098-99B7-500BC8B3B777Q30967137-DD2A5604-F364-4C4A-B70A-DF37922601B6Q31027392-4E6B8A4A-035A-4290-83EC-29ACB8BEB40FQ33223740-CBD34A2E-9831-4004-A823-3EBAC8C1EEACQ33261308-B27910A2-B275-4F70-A1B0-5A6ED64B15C1Q33302903-B778BE7D-EBA7-4EA4-9BC7-731273F3C598Q33319552-7BE863A0-D649-41F3-91A2-6841B83F54A1Q33359552-A1DE626C-50A6-47D8-9257-81F93571B45FQ33361102-F6D1DBBD-4E2D-4D32-8612-1AC847285B18Q33499694-6538EBBE-2643-49B7-B618-D95F87F78377Q33558449-19034CFC-0EF3-4F65-AAA2-BE037DC22A9AQ33598040-BA7498F8-52E4-45F7-A069-921C8D56B288Q33701044-428FD487-7685-4AC4-A393-D8E0081285AAQ33742070-703DBCFB-5285-4E5A-86D5-8DE8A3AC00A2Q33788306-036214BB-8C42-40FB-B36C-5F730ACD9863Q33835382-A194323A-3FDB-4F74-950C-48EC9C7CCEF2Q33838368-FCB4021B-84C9-449D-AFFD-D3E8296F7C52Q33883252-638A7368-B95C-48C9-A317-1BE5911372F9Q33925720-210B548D-55BE-4D11-AD0C-B89C49918FBFQ33943794-97DD6D56-953B-405F-BCD7-31D0BD6810EAQ34122492-2F73ED71-5CDC-4EB9-9DF8-8D9CFBC2DCA0Q34129066-F747D210-56E3-4FF8-AC00-2CBF36CBA236Q34260615-904B5110-926A-4DA7-9F06-E78263B4E23CQ34260722-EF356360-696F-47DC-814C-0B4C7412D0C4Q34842236-4D7801E1-64CB-4F65-A086-0F9846435FA7Q35073867-29A5EAEE-6703-4702-8CA8-1A9557BD141EQ35606847-BC1B0EF8-D9E5-4D67-965E-51E33F2B1931Q36148809-04940C69-1373-4231-8B99-B1E270044263Q36226232-DC747D0B-4B9E-44B2-A25A-28D961E4917FQ36314049-25AFA9CF-A7DF-4CAF-8BE6-E0639B137385Q36446656-4090D8C8-7FD6-4438-A317-646D881F9813Q36710710-7677B053-4FC0-4DD1-82D0-9E4A59C31DA2Q36785777-A4E52EC2-71DC-4D0B-84FB-068302CBD673Q37264651-8FD1D695-59DF-4468-8145-9EDE7BE9F50B
P2860
Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunization with parasite-der ...... elii YM blood-stage infection.
@ast
Immunization with parasite-der ...... elii YM blood-stage infection.
@en
Immunization with parasite-der ...... elii YM blood-stage infection.
@nl
type
label
Immunization with parasite-der ...... elii YM blood-stage infection.
@ast
Immunization with parasite-der ...... elii YM blood-stage infection.
@en
Immunization with parasite-der ...... elii YM blood-stage infection.
@nl
prefLabel
Immunization with parasite-der ...... elii YM blood-stage infection.
@ast
Immunization with parasite-der ...... elii YM blood-stage infection.
@en
Immunization with parasite-der ...... elii YM blood-stage infection.
@nl
P2093
P2860
P921
P1476
Immunization with parasite-der ...... elii YM blood-stage infection.
@en
P2093
P2860
P304
P356
10.1128/IAI.68.5.2899-2906.2000
P407
P577
2000-05-01T00:00:00Z